Anavex Life Sciences Corp (AVXL)

[abew4me]

Exactly. I think the analyst, Ram Selvaraju, was the one that brought everything to light in his statement/question below

Ram Selvaraju

The involvement of the CHMP, that review committee that typically looks at drug candidates that are subjected -- submitted to the EMA for approval and renders a positive or a negative opinion prior to an approval decision being taken. Just wanted to know when you expect the CHMP to get involved in the review of the blarcamesine MAA and what criteria you expect them to use to determine what their opinion should be?

IMO, that is exactly why there is an 83% approval rate for those companies that submit their applications to them. They basically get a thumbs up or down prior to an approval decision.